|
Dallas.
Cervical cancer might become easier to detect with a new test than
with the standard Pap smear test.
Researchers
at the University of Texas Southwestern Medical Center at Dallas
reported the results of a study, which indicates that the relatively
new fluid-based Pap test ThinPrep Pap is a better way to screen
for cervical cancer.
The
study found that the layer of liquid used for the ThinPrep Pap allows
for more accurate identification of cells or bits of cells, DNA
proteins and bits of proteins, all of which are associated with
cancer or precancerous conditions. The test offers a relatively
simple way for molecular changes in cell samples to be analyzed.
Researchers
believe this process could lead to the development of biomarkers
identifying women at risk for cervical cancer and optimize chemoprevention
strategies for these cancers.
"Our
study shows that it is possible to conduct multiple analyses of
DNA and protein levels of bits of cells from the cervical area using
the leftover cells from the widely used, simple-to-perform, fluid-based
ThinPrep Pap test," said Carolyn Muller, MD, lead researcher
and assistant professor of obstetrics and gynecology at UT Southwestern.
The
ThinPrep Pap is ideal for attempting to find risk-assessment biomarkers
because its alcohol-based liquid can maintain the integrity of the
various protein specimens while preserving them, Muller said. Also,
only a fraction of the sample is used for the clinical Pap smear,
allowing for further testing of the sample, she said.
The
study appeared in the Aug. 11 issue of the Journal of Obstetrics
and Gynecology.
|